{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:05:19Z","timestamp":1787000719128,"version":"build-2736575974"},"reference-count":172,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T00:00:00Z","timestamp":1220486400000},"content-version":"vor","delay-in-days":3169,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biotechnology Progress"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>During the next decade or so, there will be significant and impressive advances in biomolecular engineering, especially in our understanding of the biological roles of various biomolecules inside the cell. The advances in high throughput screening technology for discovery of target molecules and the accumulation of functional genomics and proteomics data at accelerating rates will enable us to design and discover novel biomolecules and proteins on a rational basis in diverse areas of pharmaceutical, agricultural, industrial, and environmental applications. As an applied molecular evolution technology, DNA shuffling will play a key role in biomolecular engineering. In contrast to the point mutation techniques, DNA shuffling exchanges large functional domains of sequences to search for the best candidate molecule, thus mimicking and accelerating the process of sexual recombination in the evolution of life. The phage\u2010display system of combinatorial peptide libraries will be extensively exploited to design and create many novel proteins, as a result of the relative ease of screening and identifying desirable proteins. Even though this system has so far been employed mainly in screening the combinatorial antibody libraries, its application will be extended further into the science of protein\u2010receptor or protein\u2010ligand interactions. The bioinformatics for genome and proteome analyses will contribute substantially toward ever more accelerated advances in the pharmaceutical industry. Biomolecular engineering will no doubt become one of the most important scientific disciplines, because it will enable systematic and comprehensive analyses of gene expression patterns in both normal and diseased cells, as well as the discovery of many new high\u2010value molecules. When the functional genomics database, EST and SAGE techniques, microarray technique, and proteome analysis by 2\u2010dimensional gel electrophoresis or capillary electrophoresis in combination with mass spectrometer are all put to good use, biomolecular engineering research will yield new drug discoveries, improved therapies, and significantly improved or new bioprocess technology. With the advances in biomolecular engineering, the rate of finding new high\u2010value peptides or proteins, including antibodies, vaccines, enzymes, and therapeutic peptides, will continue to accelerate. The targets for the rational design of biomolecules will be broad, diverse, and complex, but many application goals can be achieved through the expansion of knowledge based on biomolecules and their roles and functions in cells and tissues. Some engineered biomolecules, including humanized Mab's, have already entered the clinical trials for therapeutic uses. Early results of the trials and their efficacy are positive and encouraging. Among them, Herceptin, a humanized Mab for breast cancer treatment, became the first drug designed by a biomolecular engineering approach and was approved by the FDA. Soon, new therapeutic drugs and high\u2010value biomolecules will be designed and produced by biomolecular engineering for the treatment or prevention of not\u2010so\u2010easily cured diseases such as cancers, genetic diseases, age\u2010related diseases, and other metabolic diseases. Many more industrial enzymes, which will be engineered to confer desirable properties for the process improvement and manufacturing of high\u2010value biomolecular products at a lower production cost, are also anticipated. New metabolites, including novel antibiotics that are active against resistant strains, will also be produced soon by recombinant organisms having de novo engineered biosynthetic pathway enzyme systems. The biomolecular engineering era is here, and many of benefits will be derived from this field of scientific research for years to come if we are willing to put it to good use.<\/jats:p>","DOI":"10.1021\/bp088059d","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T01:53:38Z","timestamp":1027648418000},"page":"2-16","source":"Crossref","is-referenced-by-count":100,"title":["Recent Progress in Biomolecular Engineering"],"prefix":"10.1002","volume":"16","author":[{"given":"Dewey D. Y.","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo\u2010Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.4.9.863"},{"key":"e_1_2_6_3_1","first-page":"485","article-title":"Increased Affinity Leads to Improved Selective Tumor Delivery of Single\u2010chain Fv Antibodies","volume":"58","author":"Adams G. P.","year":"1998","journal-title":"Cancer"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.233"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.20.10856"},{"key":"e_1_2_6_6_1","first-page":"2825","article-title":"A Single\u2010chain Immunotoxin against Carcinoembryonic Antigen that Suppresses Growth of Colorectal Carcinoma Cells","volume":"4","author":"Akamatsu Y.","year":"1998","journal-title":"Clin. Cancer Res"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.1150191103"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(97)80118-8"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1997.0175"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.6054"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-9084(85)80160-7"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00041a006"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi961543h"},{"key":"e_1_2_6_14_1","first-page":"2825","article-title":"Recombinant Humanized Anti\u2010HER2 Antibody Herceptin Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2\/neu Overexpressing Human Breast Cancer Xenografts","volume":"58","author":"Baselga J.","year":"1998","journal-title":"Cancer Res."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.737"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.1998.11740538"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(97)80066-3"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0047-6374(98)00045-1"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1995.11.1335"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.4.1709"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00062a001"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/312643a0"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90183-7"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1998.14.1369"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.d01-650.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)01611-1"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(97)80068-7"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.17.6709"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-3565(25)22698-2","article-title":"Humanized Monoclonal Antibody DREG\u2010200 Directed against L\u2010Selectin Projects in Feline Myocardial Reperfusion Injury","volume":"271","author":"Buerke M.","year":"1994","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.2.1.28"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5386.63"},{"key":"e_1_2_6_32_1","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood.V83.7.1760.1760","article-title":"A Phase 1B Trial of Humanized Monoclonal Antibody M195(Anti\u2010CD33) in Myeloid Leukemia: Specific Targeting without Immunogenecity","volume":"83","author":"Caron P. C.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(98)80015-3"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(97)80067-5"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70202-1"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jim.2900416"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1515\/BC.1999.103"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)00264-4"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/9.6.499"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.7.5757-5761.1998"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-3803(199808)42:03\/04<135::AID-FOOD135>3.0.CO;2-6"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5319.1696"},{"key":"e_1_2_6_43_1","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1128\/iai.61.6.2462-2467.1993","article-title":"A Recombinant 15\u2010Kilodalton Carboxy\u2010terminal Fragment of Plasmodium yoelii 17XL Merozoit Surface Protein 1 Induces a Protective Immune Response in Mice","volume":"61","author":"Daly T. M.","year":"1993","journal-title":"Infect. Immunol"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0896(95)00104-O"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2516(97)89893-7"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/8.10.1029"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00101-6"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.40.25304"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199509000-00004"},{"key":"e_1_2_6_50_1","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.4049\/jimmunol.156.9.3151","article-title":"Peptide\u2010based, but not Whole Protein, Vaccines Elicit Immunity to HER\u20102\/neu, Oncogenic Self\u2010protein","volume":"156","author":"Disis M. L.","year":"1996","journal-title":"J. Immunol."},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0695-583"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.3.463"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1995.1111"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(92)91010-M"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1998.00323.x"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0398-267"},{"key":"e_1_2_6_57_1","first-page":"37","article-title":"Site\u2010directed Mutagenesis and Its Application to Protein Folding","volume":"14","author":"Garvey E. P.","year":"1990","journal-title":"Biotechnology"},{"key":"e_1_2_6_58_1","first-page":"3733","article-title":"Development of Antiangiogenin Peptide Using a Phage\u2010displayed Peptide Library","volume":"57","author":"Goh Y. S.","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.2.330"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.1996.0264"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1999.3033"},{"key":"e_1_2_6_62_1","first-page":"277","volume-title":"Antibody Therapeutics","author":"Hakimi J.","year":"1997"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1086\/514040"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/9.11.1723"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.1150191104"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1546324"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00870265"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.2.361"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00273-3"},{"key":"e_1_2_6_70_1","first-page":"347","article-title":"The Induction of Respiratory Syncytial Virus\u2010specific Cytotoxic T\u2010cell Responses Following Immunization with a Synthetic Peptide Containing a Fusion Peptide Link to a Cytotoxic T\u2010lymphocyte Epitope","volume":"85","author":"Hsu S. C.","year":"1995","journal-title":"Immunology"},{"key":"e_1_2_6_71_1","first-page":"3055","article-title":"Minibody: a Novel Engineered Anti\u2010carcinoembryonic Antigen Antibody Fragment (Single\u2010chain Fv\u2010CH3) Which Exhibits Rapid, High\u2010level Targeting of Xenografts","volume":"56","author":"Hu S. Z.","year":"1996","journal-title":"Cancer Res."},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(98)80014-1"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2531466"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-893"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1999.tb02409.x"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.63.1535"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)00475-4"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1997.tb08312.x"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033583597003399"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1086\/514115"},{"key":"e_1_2_6_81_1","first-page":"S5899","article-title":"Treatment of Non\u2010Hodgkins Lymphoma with Radiolabeled Murine, Chimeric, or Humanized LL2, an Anti\u2010CD22 Monoclonal Antibody","volume":"55","author":"Juweid M.","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_6_82_1","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.67.4.1702-1707.1999","article-title":"Differential Protective Efficacy of DNA Vaccines Expressing Secreted Proteins of Mycobacterium Tuberculosis","volume":"67","author":"Kamath A. T.","year":"1999","journal-title":"Infect. Immunol"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja00140a043"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja9617552"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/25.16.3371"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.3.1156"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-7799(96)10046-9"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/10.4.423"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi980842z"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199708010-00004"},{"key":"e_1_2_6_91_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0037-1615133","article-title":"Comparative Studies on the Antiplatelet Effects of a Humanized Anti\u2010platelet Glycoprotein IIb\/IIIa Antibody YM337 and ReoPro under Flow Conditions","volume":"80","author":"Kuwahara M.","year":"1998","journal-title":"Thromb. Hemostasis"},{"key":"e_1_2_6_92_1","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1128\/jvi.70.5.3084-3092.1996","article-title":"Brucella abortus Conjugated with a Peptide Derived from the V3 Loop of Human Immunodeficiency Virus (HIV) Type 1 Induces HIV\u2010specific Cytotoxic T\u2010cell Responses in Normal and in CD4+ Cell\u2010depleted BALB\/c Mice","volume":"70","author":"Lapham C.","year":"1996","journal-title":"J. Virol."},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)00292-0"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00165-5"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.45.26802"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00088-I"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)00083-Y"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-79-4-831"},{"key":"e_1_2_6_99_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja972451y"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1997.93"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00274-5"},{"key":"e_1_2_6_102_1","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/JVI.72.2.1491-1496.1998","article-title":"Immunization of Pigs with a Particle\u2010mediated DNA Vaccine to Influenza A Virus Protects against Challenge with Homologous Virus","volume":"72","author":"Macklin M. D.","year":"1998","journal-title":"J. Virol."},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.1086\/515613"},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5348.199"},{"key":"e_1_2_6_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/9.6.519"},{"key":"e_1_2_6_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/12.8.681"},{"key":"e_1_2_6_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380903"},{"key":"e_1_2_6_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/348552a0"},{"key":"e_1_2_6_109_1","first-page":"549","article-title":"Rational Design of Aromatic Polyketide Natural Products by Recombinant Assembly of Enzyme Subunits","volume":"375","author":"McDaniel R.","year":"1995","journal-title":"Science"},{"key":"e_1_2_6_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001090050108"},{"key":"e_1_2_6_111_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1999.3034"},{"key":"e_1_2_6_112_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199901150-00019"},{"key":"e_1_2_6_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700053"},{"key":"e_1_2_6_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/312604a0"},{"key":"e_1_2_6_115_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi951650w"},{"key":"e_1_2_6_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(98)01204-9"},{"key":"e_1_2_6_117_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.3.531"},{"key":"e_1_2_6_118_1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1128\/jvi.69.3.1420-1428.1995","article-title":"Protection against Morbillivirus\u2010induced Encephalitis by Immunization with a Rationally Designed Synthetic Peptide Vaccine Containing B\u2010 and T\u2010Cell Epitopes from the Fusion Protein of Measles Virus","volume":"69","author":"Obeid O. E.","year":"1995","journal-title":"J. Virol"},{"key":"e_1_2_6_119_1","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.59.1152"},{"key":"e_1_2_6_120_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.450989.x"},{"key":"e_1_2_6_121_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005934621940"},{"key":"e_1_2_6_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0396-350"},{"key":"e_1_2_6_123_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0012"},{"key":"e_1_2_6_124_1","doi-asserted-by":"publisher","DOI":"10.1089\/hyb.1996.15.435"},{"key":"e_1_2_6_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(92)90008-8"},{"key":"e_1_2_6_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(97)80127-9"},{"key":"e_1_2_6_127_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2659"},{"key":"e_1_2_6_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/s007050050348"},{"key":"e_1_2_6_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(97)80075-4"},{"key":"e_1_2_6_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(91)08029-H"},{"key":"e_1_2_6_131_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1997.0973"},{"key":"e_1_2_6_132_1","first-page":"2096","article-title":"Phase I Evaluation of Humanized OKT3: Toxicity and Immunomodulatory Effects of hOKT3\u03b34","volume":"59","author":"Richards J.","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_133_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0398-321"},{"key":"e_1_2_6_134_1","doi-asserted-by":"publisher","DOI":"10.1128\/jb.179.20.6416-6425.1997"},{"key":"e_1_2_6_135_1","first-page":"98","volume-title":"Enzyme Technology for Industrial Applications","author":"Rubingh D. N.","year":"1996"},{"key":"e_1_2_6_136_1","first-page":"401","article-title":"HIV\u20101 p17 Synthetic Peptide Vaccine HGP\u201030 \u2013 Induction of Immune Response in Human Subjects and Preliminary Evidence of Protection against HIV Challenge in SCID Mice","volume":"41","author":"Sarin P. S.","year":"1995","journal-title":"Cell. Mol. Biol."},{"key":"e_1_2_6_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980119)75:2<295::AID-IJC20>3.0.CO;2-B"},{"key":"e_1_2_6_138_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5235.467"},{"key":"e_1_2_6_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(98)01219-0"},{"key":"e_1_2_6_140_1","doi-asserted-by":"publisher","DOI":"10.1038\/343038a0"},{"key":"e_1_2_6_141_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.37.21928"},{"key":"e_1_2_6_142_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.4001944"},{"key":"e_1_2_6_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/1056-8719(95)00082-7"},{"key":"e_1_2_6_144_1","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.4049\/jimmunol.151.9.4782","article-title":"Protective Immunity in Baboons Vaccinated with a Recombinant Antigen or Radiation\u2010attenuated cercariae of Schistosoma mansoni is Antibody\u2010Dependent","volume":"151","author":"Soisson L. A.","year":"1993","journal-title":"J. Immunol"},{"key":"e_1_2_6_145_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7604280"},{"key":"e_1_2_6_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7519(97)00064-7"},{"key":"e_1_2_6_147_1","doi-asserted-by":"publisher","DOI":"10.1038\/370389a0"},{"key":"e_1_2_6_148_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.22.10747"},{"key":"e_1_2_6_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(93)90169-X"},{"key":"e_1_2_6_150_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0795-669"},{"key":"e_1_2_6_151_1","first-page":"98","volume-title":"Enzyme Technology for Industrial Applications","author":"Svensen A.","year":"1996"},{"key":"e_1_2_6_152_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.44.27943"},{"key":"e_1_2_6_153_1","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1128\/IAI.66.9.4526-4530.1998","article-title":"Synthesis and Characterization of a Protective Peptide\u2010based Vaccine against","volume":"66","author":"Tarrab\u2010Hazdai R.","year":"1998","journal-title":"Schistosoma mansoni. Infect. Immun"},{"key":"e_1_2_6_154_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240104"},{"key":"e_1_2_6_155_1","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood.V90.6.2437","article-title":"New Xenograft Model of Multiple Myeloma and Efficacy of a Humanized Antibody against Human Interleukin\u20106 Receptor","volume":"90","author":"Tsunenari T.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_156_1","doi-asserted-by":"publisher","DOI":"10.1080\/10409239991209165"},{"key":"e_1_2_6_157_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.5.2056"},{"key":"e_1_2_6_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0698-535"},{"key":"e_1_2_6_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)01484-5"},{"key":"e_1_2_6_160_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199701150-00007"},{"key":"e_1_2_6_161_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.14.6404"},{"key":"e_1_2_6_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-7799(90)90189-5"},{"key":"e_1_2_6_163_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.476"},{"key":"e_1_2_6_164_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780381110"},{"key":"e_1_2_6_165_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3201242"},{"key":"e_1_2_6_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)00278-4"},{"key":"e_1_2_6_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(98)00023-2"},{"key":"e_1_2_6_168_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5274.458"},{"key":"e_1_2_6_169_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1995.tb01047.x"},{"key":"e_1_2_6_170_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1998.6876"},{"key":"e_1_2_6_171_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00832010"},{"key":"e_1_2_6_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(97)80119-X"},{"key":"e_1_2_6_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0958-1669(98)80017-7"}],"container-title":["Biotechnology Progress"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1021%2Fbp088059d","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aiche.onlinelibrary.wiley.com\/doi\/pdf\/10.1021\/bp088059d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:15:32Z","timestamp":1760040932000},"score":1,"resource":{"primary":{"URL":"https:\/\/aiche.onlinelibrary.wiley.com\/doi\/10.1021\/bp088059d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":172,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1021\/bp088059d"],"URL":"https:\/\/doi.org\/10.1021\/bp088059d","archive":["Portico"],"relation":{},"ISSN":["8756-7938","1520-6033"],"issn-type":[{"value":"8756-7938","type":"print"},{"value":"1520-6033","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}